The Efficacy Of The Wavelight Mydon Laser for Hair Removal And Treatment of Leg Veins
Determine The Efficacy Of The Wavelight Mydon Laser For Hair Removal And Treatment of Leg Veins
1 other identifier
interventional
10
1 country
1
Brief Summary
This study is being done to compare the efficacy of an FDA cleared laser device with other similar systems in the market for the treatment of leg veins and hair removal in patients with darker skin type.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2004
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2006
CompletedFirst Submitted
Initial submission to the registry
August 19, 2006
CompletedFirst Posted
Study publicly available on registry
August 22, 2006
CompletedApril 7, 2015
April 1, 2015
1.5 years
August 19, 2006
April 6, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Safety and efficacy of the treatment will determine the outcome.
6 months
Study Arms (1)
Device
NO INTERVENTIONInterventions
The laser treatment involves the use of an FDA approved laser device (510K Clearance certificate) for hair removal and treatment of leg veins for females having skin types III - VI. The pulses are of appropriate energy and pulse duration based on the skin type.
To determine efficacy of FDA approved Laser treatment for hair removal and leg veins. The Mydon Wavelight is a Long Pulsed Nd Yag Laser, Class IV 1064 nm 55W
Eligibility Criteria
You may qualify if:
- Female patients of Asian and darker skin type greater than or equal to 18 years of age.
- Ability to give informed consent.
You may not qualify if:
- Pregnancy.
- Taking medications that are photosensitizing.
- History of skin disease in the area to be treated over the last 6 months.
- Ongoing cutaneous lupus erythematosus, morphea, alopecia areata, or severe folliculitis.
- History of keloidal or hypertrophic scarring.
- Have inadequate hair growth in the test area of axilla.
- Have unrealistic expectations of the treatment.
- Co-existing severe emotional, medical or surgical illness leading to the inability to meet the follow-up requirements.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California, Davis Medical Center Department of Dermatology
Sacramento, California, 95816, United States
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel B Eisen, M.D.
University of California, Davis
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 19, 2006
First Posted
August 22, 2006
Study Start
October 1, 2004
Primary Completion
April 1, 2006
Study Completion
April 1, 2006
Last Updated
April 7, 2015
Record last verified: 2015-04